| 支气管肺泡灌洗术联合局部应用敏感抗生素对慢性阻塞性肺疾病合并支气管扩张患者的疗效题录 |
| |
| 引用本文： | 李书阅,董亮亮,张洪月,宁康.支气管肺泡灌洗术联合局部应用敏感抗生素对慢性阻塞性肺疾病合并支气管扩张患者的疗效题录[J].国际医药卫生导报,2023,29(1):53. |
| |
| 作者姓名： | 李书阅 董亮亮 张洪月 宁康 |
| |
| 作者单位： | 1聊城市第二人民医院呼吸科，聊城 252600；2山东第一医科大学第一附属医院呼吸与危重症医学科，济南 250013 |
| |
| 基金项目： | 山东省自然科学基金（ZR2021MH200） |
| |
| 摘 要： | 目的分析支气管肺泡灌洗术(BAL)联合局部应用敏感抗生素对慢性阻塞性肺疾病(慢阻肺)合并支气管扩张患者的肺功能、血气分析、炎症因子和气道阻力的影响。方法回顾性分析2018年1月至2021年1月在聊城市第二人民医院接受治疗的慢阻肺合并支气管扩张患者154例, 根据患者是否接受BAL将其分为对照组(63例)和观察组(91例)。对照组男35例、女28例, 年龄(58.3±8.3)岁, 采用常规治疗;观察组男56例、女35例, 年龄(57.8±7.1)岁, 在对照组基础上结合BAL治疗。比较两组治疗前和治疗10 d后肺功能指标肺活量(VC)、第1秒用力呼气量(FEV1)、FEV1占用力肺活量比值(FEV1/FVC)、FEV1占预计值比值(FEV1/pre)、最大呼气流速峰值(PEF)]、血气分析指标动脉血氧分压(PaO2)、动脉血氧饱和度(SaO2)、动脉血二氧化碳分压(PaCO2)]、炎症因子水平超敏-C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、降钙素原(PCT)、白细胞介素-6(IL-6)]、气道阻力指标响应频率(Fres)、呼吸总阻抗(Zrs)、5 Hz时总气道阻...
|
| 关 键 词： | 支气管肺泡灌洗 慢性阻塞性肺疾病 支气管扩张 肺功能 炎症因子 气道阻力 |
Effect of bronchoalveolar lavage combined with local application of sensitive antibiotics on patients with chronic obstructive pulmonary disease complicated with bronchiectasis |
| |
| Li Shuyue,Dong Liangliang,Zhang Hongyue,Ning Kang.Effect of bronchoalveolar lavage combined with local application of sensitive antibiotics on patients with chronic obstructive pulmonary disease complicated with bronchiectasis[J].International Medicine & Health Guidance News,2023,29(1):53. |
| |
| Authors: | Li Shuyue Dong Liangliang Zhang Hongyue Ning Kang |
| |
| Affiliation: | 1 Department of Respiratory Medicine, The Second People's Hospital of Liaocheng, Liaocheng 252600, China; 2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan 250013, China |
| |
| Abstract: | Objective To analyze the effects of bronchoalveolar lavage (BAL) combined with local application of sensitive antibiotics on pulmonary function, blood gas analysis, inflammatory factors, and airway resistance in patients with chronic obstructive pulmonary disease (COPD) and bronchiectasis. Methods A retrospective analysis was made on 154 patients with COPD and bronchiectasis who were treated in The Second People's Hospital of Liaocheng from January 2018 to January 2021. They were divided into a control group (63 cases) and an observation group (91 cases) according to whether they received BAL or not. In the control group, 35 males and 28 females, aged (58.3±8.3) years, received routine treatment; in the observation group, 56 males and 35 females, aged (57.8±7.1) years, were treated with BAL on the basis of the control group. The changes of pulmonary function indexes vital capacity (VC), forced expiratory volume in the first second (FEV1), ratio of FEV1 to forced vital capacity (FEV1/FVC), ratio of FEV1 to predicted value (FEV1/pre), and peak expiratory flow rate (PEF)], blood gas analysis indexes arterial partial pressure of oxygen (PaO2), arterial oxygen saturation (SaO2), and arterial partial pressure of carbon dioxide (PaCO2)], levels of inflammatory factors high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), procalcitonin (PCT), and interleukin-6 (IL-6)], and airway resistance indexes response frequency (Fres), total respiratory resistance (Zrs), total airway resistance/predicted value at 5 Hz (R5/pre), central airway resistance/predicted value (R20/pre), and peripheral elastic resistance (X5)] before and after 10 d of treatment and the total effective rates of the two groups were compared. t test and χ2 test were used. Results After treatment, the levels of VC (2.8±0.4) L], FEV1 (1.9±0.4) L], FEV1/FVC (74.5±11.6) %], FEV1/pre (83.2±10.2) %], and PEF (6.3±1.2) L/s] in the observation group were higher than those in the control group (2.3±0.3) L,(1.5±0.3) L, (68.2±12.9) %, (76.8±9.2) %, and (5.9±1.1) L/s], with statistically significant differences (all P<0.05). After treatment, the PaO2 (84.9±6.3) %] and SaO2(89.4±10.2) %] in the observation group were higher than those in the control group (78.9±7.1) % and (84.3±7.5) %], but the PaCO2 (36.9±5.1) mmHg (1 mmHg=0.133 kPa)] was lower than that in the control group (42.8±5.3) mmHg], with statistically significant differences (all P<0.05). After treatment, the levels of hs-CRP (4.3±0.9) mg/L], TNF-α (6.3±1.2) ng/L], PCT (1.5±0.3) μg/L], and IL-6 (8.4±2.1) ng/L] in the observation group were lower than those in the control group (8.6±2.1) mg/L, (12.3±3.1) ng/L, (3.2±0.7) μg/L, and (20.3±3.5) ng/L], with statistically significant differences (all P<0.05). After treatment, the Fres (18.7±4.6) Hz], Zrs (0.4±0.1) kPa/(L·s)], R5/pre (184.3±20.5) %], and R20/pre (186.9±13.8) %] in the observation group were all lower than those in the control group (20.6±4.3) Hz, (0.7±0.1) kPa/(L·s), (203.1±25.8) %, and (215.3±15.0) %], with statistically significant differences (all P<0.05). The total effective rate of the observation group was 85.7% (78/91), which was higher than that of the control group 65.1% (41/63)], with a statistically significant difference (χ2=9.026, P=0.003). Conclusion BAL combined with local application of sensitive antibiotics can effectively improve the blood gas value in COPD patients with bronchiectasis, and reduce the inflammatory reaction and airway resistance, thus effectively improving the lung function and clinical treatment effect. |
| |
| Keywords: | Bronchoalveolar lavage Chronic obstructive pulmonary disease Bronchiectasis Lung function Inflammatory factors Airway resistance |
|
| 点击此处可从《国际医药卫生导报》浏览原始摘要信息 |
|
点击此处可从《国际医药卫生导报》下载全文 |
|
